ProPharma Group has announced the acquisition of Washington D.C.-based The Weinberg Group, which also provides regulatory and compliance services to the pharmaceutical, biotech, and medical device industries.
“This acquisition further solidifies ProPharma Group’s position as a leading, globally integrated pharmaceutical services platform with world class regulatory affairs and compliance services,” said Michael Farah, chairman of ProPharma Group and partner at its corporate parent, Linden Capital Partners. “We are confident the combination will accelerate ProPharma Group’s growth and enhance its reputation as a value-added partner to its clients.”
In a news release announcing the deal, ProPharma Group said its service offering will expand to include highly specialized, U.S. based pre-approval/pre-clinical regulatory services, effectively establishing a true, end-to-end solution for its clients across the globe. The company, based in Overland Park, now has more than 1,100 employees across United States, Canada, Europe, Japan, and Australia.